ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play
- PMID: 33619166
- DOI: 10.1136/gutjnl-2020-323924
ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play
Keywords: colorectal cancer; drug resistance; stem cells.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. Gut. 2022. PMID: 33436496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous